United States 119th Congress Status: In Committee Bipartisan · 21 D · 20 R cosponsors

S 3267 — ASAP Act

Last action — Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S8278-8279)

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced November 20, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 41 sponsors

    1 primary, 40 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (21 D · 20 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

3 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill adds Medicare coverage for blood-based dementia screening tests, including specific criteria for such tests starting January 1, 2028.

  • 42 U.S.C. 1395x

    Alzheimer's disease and related dementias early detection screening tests (as defined in subsection (nnn));

    This amendment adds a new type of screening test for Alzheimer's disease and related dementias to the list of services covered by Medicare.

  • 42 U.S.C. 1395x

    The term `Alzheimer's disease and related dementias early detection screening test' means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer's disease or related dementias on or after January 1, 2028, that-- `(1) is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and `(2) is-- `(A) a genomic sequencing blood or blood product test; or `(B) such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A).

    This establishes a clear definition and criteria for what constitutes an Alzheimer's disease and related dementias early detection screening test.

  • 42 U.S.C. 1395l(h)(1)(A)

    Alzheimer's disease and related dementias early detection screening tests under section 1861(nnn) and

    This addition specifies that payment for Alzheimer's screening tests will be included in Medicare reimbursements.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S8278-8279)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 40 co-sponsors · 506 not signed on

Sponsors (1)

Co-sponsors (40)

Not signed on (506)

506 members have not signed on to this bill.

Show all 506 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 3267?
S 3267 is sponsored by Collins, Susan M. (Republican), Cortez Masto, Catherine (Democratic), Capito, Shelley Moore (Republican), Warner, Mark R. (Democratic), Banks, Jim (Republican), Lankford, James (Republican), Kennedy, John (Republican), Duckworth, Tammy (Democratic), Booker, Cory A. (Democratic), Moran, Jerry (Republican), Tillis, Thomas (Republican), Daines, Steve (Republican), Fischer, Deb (Republican), Murkowski, Lisa (Republican), Scott, Rick (Republican), Cramer, Kevin (Republican), Hyde-Smith, Cindy (Republican), Rounds, Mike (Republican), Britt, Katie Boyd (Republican), Klobuchar, Amy (Democratic), Coons, Christopher A. (Democratic), Gillibrand, Kirsten E. (Democratic), Armstrong, Alan (Republican), Wicker, Roger F. (Republican), Kelly, Mark (Democratic), Hoeven, John (Republican), Hirono, Mazie K. (Democratic), Smith, Tina (Democratic), Van Hollen, Chris (Democratic), Cantwell, Maria (Democratic), Shaheen, Jeanne (Democratic), Reed, Jack (Democratic), Kim, Andy (Democratic), Slotkin, Elissa (Democratic), Blunt Rochester, Lisa (Democratic), Gallego, Ruben (Democratic), Risch, James E. (Republican), Welch, Peter (Democratic), Padilla, Alex (Democratic), Heinrich, Martin (Democratic), and McCormick, David (Republican).
What is the current status of S 3267?
This bill is in committee in the Senate. Introduced November 20, 2025. It must pass committee before a floor vote.
Where can I track S 3267?
Track S 3267 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3267

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 3267

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →